Sensitivity in detecting osseous lesions depends on anatomic localization: Planar bone scintigraphy versus 18F PET

Journal of Nuclear Medicine

Volumn 40, Issue 10, 1999, Pages 1623-1629

  Schirrmeister, Holger ^a   Guhlmann, Albrecht ^a   Elsner, Klaus ^a   Kotzerke, Jörg ^a   Glatting, Gerhard ^a   Rentschler, Marion ^a   Neumaier, Bernd ^a   Träger, Harald ^a   Nüssle, Karin ^a   Reske, Sven N ^a,b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

18F PET; Bone metastases; Radionuclide bone scanning

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 131;

ARTICLE; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; HUMAN; INTERMETHOD COMPARISON; LUNG CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CARCINOMA; RECEIVER OPERATING CHARACTERISTIC; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THYROID CARCINOMA;

BONE NEOPLASMS; FALSE NEGATIVE REACTIONS; FLUORINE RADIOISOTOPES; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; SODIUM FLUORIDE; TECHNETIUM TC 99M MEDRONATE; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032887593     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987;55:61-66.
2. Noguchi S, Miyauchi K, Nishizawa Y, Imaoka S, Koyama H, Iwanaga T. Results of surgical treatment for sternal metastasis of breast cancer. Cancer. 1988;62:1397-1401.
3. Needham PR, Hoskin PJ. Radiotherapy of painful bone metastases. Palliat Med. 1994;8:95-104.
4. van Holten-Verzahntvoort AT, Bijvoet OL, Cleton FJ, et al. Reduced morbidity from skeletal metastases in breast cancer patients during long-term biphosphonate-treatment. Lancet. 1987;31:983-985.
5. Sasaki A, Boyce BF, Story B, et al. Bisphosphonate residronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res. 1995;55:3551-3557.
6. Traill Z, Richards MA, Moore NR. Magnetic resonance imaging of metastatic bone disease. Clin Orthop. 1995;312:76-88.
7. Franks JA, Ling A, Patronas NJ, et al. Detection of malignant bone tumors: MR imaging vs scintigraphy. AJR. 1990;155:1043-1048.
8. Brown B, Laorr A, Greenspan A, Stadalnik R. Negative bone scintigraphy with diffuse osteoblastic breast carcinoma metastases. Clin Nucl Med. 1994;19: 194-196.
9. Haubold-Reuter, Duewell S, Schilcher Marincek B, Schulthess GK. The value of bone scintigraphy, bone marrow scintigraphy and fast spin magnetic resonance imaging in staging of patients with malignant solid tumors: a prospective study. Eur J Nucl Med. 1993;20:1063-1069.
10. Avrami E, Tadmor R, Dally O, Hadar H. Early MR demonstration of spinal metastases in patients with normal radiographs and CT and radionuclide bone scans. J Comput Assist Tomogr. 1989;13:598-602.
11. 18F, and skeletal scintigraphy. Radiology. 1973;107:551-555.
12. 18F for bone imaging. AJR. 1974;121:184-190.
13. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characterisitic curves from the same cases. Radiology. 1983;148:839-843.
14. Krasnow AZ, Hellman RS, Timins ME, Collier BD, Anderson T, Isitman AT. Diagnostic bone scanning in oncology. Semin Nucl Med. 1997;27:107-141.
15. Batson OV. The function of the vertebral veins and their role in the spread of metastases. Clin Orthop. 1995;312:4-9.
16. Kosuda S, Tatsumi K, Yokoyama H, et al. Does bone SPECT actually have lower sensitivity for detecting vertebral metastases than MRI? J Nucl Med. 1996;37:975-978.
17. Even-Sapir E, Martin RH, Barnes DC, Pringle CR, Iles SE, Mitchell MJ. Role of SPECT in differentiating malignant from benign lesions in the lower thoracic and lumbar vertebrae. Radiology. 1993;187:193-198.
18. Donhoe KJ, Henkin RE, Royal HD, et al. Procedure guideline for bone scintigraphy: 1.0. J Nucl Med. 1996;37:1903-1906.
19. Reske SN, Karstens JH, Gloeckner W, et al. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet. 1989;11:299-301.
20. Pantel K, Izbicki J, Passlick B, et al. Frequency and prognostic significance of isolated tumor cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet. 1996;347:649-653.
21. Kamby C, Vejeborg I, Daugaard S, et al. Clinical and radiologic characteristics of bone metastases in breast cancer. Cancer. 1987;60:2524-2531.
22. 18F-ion and PET. J Comput Assist Tomogr. 1993;17:34-41.
23. Hawkins RA, Choi Y, Huang SC, et al. Evaluation of skeletal kinetics of fluorine 18-fluoride ion with PET. J Nucl Med. 1992;33:633-642.
24. Schiepers C, Nuyts J, Bormans G, et al. Fluoride kinetics of the axial skeleton measured in vivo with ftuorine-18-fluoride PET J Nucl Med. 1997;38:1970-1976.
25. Puig S, Staudenherz A, Steiner S, Eisenhuber E, Leitha T. Differential diagnosis of atypically located single or double hot spots in whole body scanning. J Nucl Med. 1998;39:1263-1266.
26. 18FNa-PET and comparison with planar skeletal scintigraphy. Fortschr Röntgenstr. 1998;168:451-456.